Agios Pharma (NASDAQ: AGIO) reported Q2 EPS of ($1.93), $0.12 worse than the analyst estimate of ($1.81). Revenue for the quarter came in at $12.45 million versus the consensus estimate of $9.54 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.